TY - JOUR
T1 - Long-Term Course of Chronic Hepatitis C in Children
T2 - From Viral Clearance to End-Stage Liver Disease
AU - Bortolotti, Flavia
AU - Verucchi, Gabriella
AU - Cammà, Calogero
AU - Cabibbo, Giuseppe
AU - Zancan, Lucia
AU - Indolfi, Giuseppe
AU - Giacchino, Raffaella
AU - Marcellini, Matilde
AU - Marazzi, Maria Grazia
AU - Barbera, Cristiana
AU - Maggiore, Giuseppe
AU - Vajro, Pietro
AU - Bartolacci, Samuela
AU - Balli, Fiorella
AU - Maccabruni, Anna
AU - Guido, Maria
PY - 2008/6
Y1 - 2008/6
N2 - Background & Aims: The natural course of chronic hepatitis C (CHC) in children is not well understood. The aim of this study was to assess the long-term course of CHC in a large sample of otherwise healthy children. Methods: From 1990 to 2005, 504 consecutive antihepatitis C virus (HCV)-positive children were enrolled at 12 centers of a national observatory and were followed up retrospectively/prospectively. Results: Putative exposure was perinatal in 283 (56.2%) cases, parenteral in 158 (31.3%), and unknown in 63 (12.5%). At baseline, 477 (94.6%) cases were HCV RNA seropositive, 118 (24.7%) of which were treated with standard interferon α. Ten years after putative exposure, the outcome in 359 HCV RNA-positive, untreated patients was (1) undetectable viremia in 27 (7.5%) (by Cox regression analysis, spontaneous viral clearance was independently predicted by genotype 3 [hazard ratio 6.44; 95% confidence interval: 2.7-15.5]) and (2) persistent viremia in 332 (92%) cases. Six of these 332 cases (1.8%) progressed to decompensated cirrhosis (mean age, 9.6 years). This latter group included 5 Italian children perinatally infected with genotype 1a (4 of the mothers were drug users). Thirty-three (27.9%) treated patients achieved a sustained virologic response. Conclusions: Over the course of a decade, few children with chronic HCV infection cleared viremia spontaneously, and those who did were more likely to have genotype 3. Persistent viral replication led to end-stage liver disease in a small subgroup characterized by perinatal exposure, maternal drug use, and infection with HCV genotype 1a. Children with such features should be considered for early treatment.
AB - Background & Aims: The natural course of chronic hepatitis C (CHC) in children is not well understood. The aim of this study was to assess the long-term course of CHC in a large sample of otherwise healthy children. Methods: From 1990 to 2005, 504 consecutive antihepatitis C virus (HCV)-positive children were enrolled at 12 centers of a national observatory and were followed up retrospectively/prospectively. Results: Putative exposure was perinatal in 283 (56.2%) cases, parenteral in 158 (31.3%), and unknown in 63 (12.5%). At baseline, 477 (94.6%) cases were HCV RNA seropositive, 118 (24.7%) of which were treated with standard interferon α. Ten years after putative exposure, the outcome in 359 HCV RNA-positive, untreated patients was (1) undetectable viremia in 27 (7.5%) (by Cox regression analysis, spontaneous viral clearance was independently predicted by genotype 3 [hazard ratio 6.44; 95% confidence interval: 2.7-15.5]) and (2) persistent viremia in 332 (92%) cases. Six of these 332 cases (1.8%) progressed to decompensated cirrhosis (mean age, 9.6 years). This latter group included 5 Italian children perinatally infected with genotype 1a (4 of the mothers were drug users). Thirty-three (27.9%) treated patients achieved a sustained virologic response. Conclusions: Over the course of a decade, few children with chronic HCV infection cleared viremia spontaneously, and those who did were more likely to have genotype 3. Persistent viral replication led to end-stage liver disease in a small subgroup characterized by perinatal exposure, maternal drug use, and infection with HCV genotype 1a. Children with such features should be considered for early treatment.
UR - http://www.scopus.com/inward/record.url?scp=44649136862&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44649136862&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2008.02.082
DO - 10.1053/j.gastro.2008.02.082
M3 - Article
C2 - 18439604
AN - SCOPUS:44649136862
VL - 134
SP - 1900
EP - 1907
JO - Gastroenterology
JF - Gastroenterology
SN - 0016-5085
IS - 7
ER -